New Delhi-Based Generic Firm Panacea Opens Fifth R&D Facility
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Generic Indian drug firm Panacea Biotec said its fifth research and development facility was opened in the suburbs of the country's financial hub Mumbai, and is aimed at delivery of conventional and biotech drugs for unmet therapeutic needs